Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to patient information

Lichen simplex chronicus

Introduction

Synonyms and keywords: Neurodermatitis, neurodermatitides, circumscribed neurodermatitis, circumscribed neurodermatitides, localized neurodermatitis, localized neurodermatitides

Overview

Overview

Lichen simplex chronicus (LSC) is a chronic skin condition associated with a persistent itch-scratch cycle, leading to a thick, leathery, dark (lichenified) skin. Similar to many other skin conditions, it may present with associated dryness, scaling, or erythema. Commonly affected regions include neck, ankles, extremities, scalp and genital region. The incidence and prevalence of the condition are not well established, but this is observed to be more common in adult female patients. The pathophysiology remains unclear, but it’s thought to arise from disturbances between central and peripheral neural tissue in the perception of itch, causing that persistent itch-scratch cycle. Several psychological disturbances like anxiety and depression have been associated with this dermatological condition.

Pathophysiology

Pathophysiology

  • Some studies tried to find genetic support to pathology of LSC. Like, Serotonin transporter (5HTT) gene polymorphism and dysfunction association to LSC [8].
  • Transient receptor potential channel A1 (TRPA1) which is seen in skin, sensory neuron and other tissues has been associated with decreased expression in the lesions of LSC. [9]
  • Long interspersed element-1 (LINE-1) pattern changes in epidermis of LSC was found in a study. [10]
Causes

Causes

Differentiating Lichen simplex chronicus from other Diseases

Differentiating Lichen simplex chronicus from other Diseases

  • Lichen simplex chronicus (LSC) must be differentiated from other diseases that cause thickened skin lesions such as:
Epidemiology and Demographics

Epidemiology and Demographics

  • LSC has been estimated to occur among 12% of the people around the world.[13]

Age

  • LSC is more commonly observed among patients aged 30 to 50 years old.

Gender

  • LSC is more commonly affected to females than males.
  • The female to male ratio is approximately 2:1.

Race

  • Previous studies in past have shown LSC more common in African Americans and Asians.
Natural History, Complications and Prognosis

Natural History, Complications and Prognosis

Diagnosis

Diagnosis

History and Symptoms

  • Diagnosis of LSC includes physical exams, history, and dermoscopy. The most common symptom is Itching.
  • LSC mostly occurs in easy to reach areas like the head, neck, extensor sides of forearm, scalp, vulva, pubis, and scrotum. It can occur as a single or multiple lesions.
  • Itching usually occurs in the nighttime, and it’s mostly absent when active.

Physical Examination

  • Lesions appear erythematous, scaly, well-demarcated, rough plaques eventually turning into thickened and hyperpigmented due to chronic pruritus.[16][17]
  • These plaques can vary in size from 3 by 6 centimeters to 6 by 10 centimeters. The color of the lesion varies according to the stage of the lesion.

Laboratory Findings

  • There are no specific laboratory findings associated with LSC.
  • You can do few tests to identify the stressor behind the disease like serum IgE levels to support underlying atopy.

Other Diagnostic Studies

Treatment

Treatment

Medical Therapy

Surgical/ Other therapy

Prevention

  • Effective measures for the primary prevention of LSC include helping patients to minimize scratching on an individual basis. Treating the underlying mental disorder if it’s involved in the etiology of disease.
References

References

  1. ↑ Juarez, Michelle C.; Kwatra, Shawn G. (2020). “A systematic review of evidence based treatments for lichen simplex chronicus”. Journal of Dermatological Treatment: 1–9. doi:10.1080/09546634.2019.1708856. ISSNΒ 0954-6634.
  2. ↑ Boozalis, Emily; Tang, Olive; Patel, Shivani; Semenov, Yevgeniy R.; Pereira, Manuel P.; Stander, Sonja; Kang, Sewon; Kwatra, Shawn G. (2018). “Ethnic differences and comorbidities of 909 prurigo nodularis patients”. Journal of the American Academy of Dermatology. 79 (4): 714–719.e3. doi:10.1016/j.jaad.2018.04.047. ISSNΒ 0190-9622.
  3. ↑ Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG (2019). “Racial and Gender Differences in the Presentation of Pruritus”. Medicines (Basel). 6 (4). doi:10.3390/medicines6040098. PMCΒ 6963580 Check |pmc= value (help). PMIDΒ 31569651.
  4. ↑ Huang, Amy H.; Canner, Joseph K.; Khanna, Raveena; Kang, Sewon; Kwatra, Shawn G. (2020). “Real-World Prevalence of Prurigo Nodularis and Burden of Associated Diseases”. Journal of Investigative Dermatology. 140 (2): 480–483.e4. doi:10.1016/j.jid.2019.07.697. ISSNΒ 0022-202X.
  5. ↑ Lotti T, Buggiani G, Prignano F (2008). “Prurigo nodularis and lichen simplex chronicus”. Dermatol Ther. 21 (1): 42–6. doi:10.1111/j.1529-8019.2008.00168.x. PMIDΒ 18318884.
  6. ↑ Tsintsadze N, Beridze L, Tsintsadze N, Krichun Y, Tsivadze N, Tsintsadze M (2015). “PSYCHOSOMATIC ASPECTS IN PATIENTS WITH DERMATOLOGIC DISEASES”. Georgian Med News (243): 70–5. PMIDΒ 26087735.
  7. ↑ Liao YH, Lin CC, Tsai PP, Shen WC, Sung FC, Kao CH (2014). “Increased risk of lichen simplex chronicus in people with anxiety disorder: a nationwide population-based retrospective cohort study”. Br J Dermatol. 170 (4): 890–4. doi:10.1111/bjd.12811. PMIDΒ 24372057.
  8. ↑ Kirtak N, Inaloz HS, AkΓ§ali C, Erdal E, Herken H, Yildirim M; et al. (2008). “Association of serotonin transporter gene-linked polymorphic region and variable number of tandem repeat polymorphism of the serotonin transporter gene in lichen simplex chronicus patients with psychiatric status”. Int J Dermatol. 47 (10): 1069–72. doi:10.1111/j.1365-4632.2008.03821.x. PMIDΒ 18986359.
  9. ↑ Qiu Y, Tang N, Zhang W, Xiong JX, Hu L, Cai T (2020). “Down-regulated expression of transient receptor potential ankyrin 1 in lichen simplex chronicus”. Ann Palliat Med. 9 (6): 3757–3765. doi:10.21037/apm-20-1712. PMIDΒ 33183050 Check |pmid= value (help).
  10. ↑ Yooyongsatit S, Ruchusatsawat K, Supiyaphun P, Noppakun N, Mutirangura A, Wongpiyabovorn J (2013). “Alterations in the LINE-1 methylation pattern in patients with lichen simplex chronicus”. Asian Pac J Allergy Immunol. 31 (1): 51–7. PMIDΒ 23517394.
  11. ↑ Shukla S, Mukherjee S (1984). “Lichen simplex chronicus during lithium treatment”. Am J Psychiatry. 141 (7): 909–10. doi:10.1176/ajp.141.7.909. PMIDΒ 6428244.
  12. ↑ Chey WY, Kim KL, Yoo TY, Lee AY (2004). “Allergic contact dermatitis from hair dye and development of lichen simplex chronicus”. Contact Dermatitis. 51 (1): 5–8. doi:10.1111/j.0105-1873.2004.00252.x. PMIDΒ 15291824.
  13. ↑ Georgieva, Filka (2016). “CURRENT EPIDEMIOLOGY OF LICHEN SIMPLEX CHRONICUS”. Journal of IMAB – Annual Proceeding (Scientific Papers). 22 (3): 1221–1225. doi:10.5272/jimab.2016223.1221. ISSNΒ 1312-773X.
  14. ↑ Juan CK, Chen HJ, Shen JL, Kao CH (2015). “Lichen Simplex Chronicus Associated With Erectile Dysfunction: A Population-Based Retrospective Cohort Study”. PLoS One. 10 (6): e0128869. doi:10.1371/journal.pone.0128869. PMCΒ 4468076. PMIDΒ 26076496.
  15. ↑ Hwang, Shang-Jyh; Juan, Chao-Kuei; Chen, Hsuan-Ju; Shen, Jui-Lung; Kao, Chia-Hung (2015). “Lichen Simplex Chronicus Associated With Erectile Dysfunction: A Population-Based Retrospective Cohort Study”. PLOS ONE. 10 (6): e0128869. doi:10.1371/journal.pone.0128869. ISSNΒ 1932-6203.
  16. ↑ Sand, Freja LΓ¦rke; Thomsen, Simon Francis (2017). “Skin diseases of the vulva: eczematous diseases and contact urticaria”. Journal of Obstetrics and Gynaecology. 38 (3): 295–300. doi:10.1080/01443615.2017.1329283. ISSNΒ 0144-3615.
  17. ↑ Chibnall, Rebecca (2017). “Vulvar Pruritus and Lichen Simplex Chronicus”. Obstetrics and Gynecology Clinics of North America. 44 (3): 379–388. doi:10.1016/j.ogc.2017.04.003. ISSNΒ 0889-8545.
  18. ↑ Fruchter R, Melnick L, Pomeranz MK (2017). “Lichenoid vulvar disease: A review”. Int J Womens Dermatol. 3 (1): 58–64. doi:10.1016/j.ijwd.2017.02.017. PMCΒ 5419035. PMIDΒ 28492056.
  19. ↑ Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U; et al. (2017). “Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade”. Open Access Maced J Med Sci. 5 (4): 556–557. doi:10.3889/oamjms.2017.133. PMCΒ 5535688. PMIDΒ 28785363.
  20. ↑ Muylaert BPB, Borges MT, Michalany AO, Scuotto CRC (2018). “Lichen simplex chronicus on the scalp: exuberant clinical, dermoscopic, and histopathological findings”. An Bras Dermatol. 93 (1): 108–110. doi:10.1590/abd1806-4841.20186493. PMCΒ 5871373. PMIDΒ 29641708.
  21. ↑ Chibnall R (2017). “Vulvar Pruritus and Lichen Simplex Chronicus”. Obstet Gynecol Clin North Am. 44 (3): 379–388. doi:10.1016/j.ogc.2017.04.003. PMIDΒ 28778638.
  22. ↑ Sand FL, Thomsen SF (2018). “Skin diseases of the vulva: eczematous diseases and contact urticaria”. J Obstet Gynaecol. 38 (3): 295–300. doi:10.1080/01443615.2017.1329283. PMIDΒ 28780897.
  23. ↑ Brunner N, Yawalkar S (1991). “A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus”. J Am Acad Dermatol. 25 (6 Pt 2): 1160–3. doi:10.1016/0190-9622(91)70317-u. PMIDΒ 1757609.
  24. ↑ Datz B, Yawalkar S (1991). “A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus”. J Am Acad Dermatol. 25 (6 Pt 2): 1157–60. doi:10.1016/0190-9622(91)70316-t. PMIDΒ 1757608.
  25. ↑ Geraldez MC, Carreon-Gavino M, Hoppe G, Costales A (1989). “Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus”. Int J Dermatol. 28 (9): 603–4. doi:10.1111/j.1365-4362.1989.tb02538.x. PMIDΒ 2583907.
  26. ↑ Day T, Bohl TG, Scurry J (2016). “Perianal lichen dermatoses: A review of 60 cases”. Australas J Dermatol. 57 (3): 210–5. doi:10.1111/ajd.12308. PMIDΒ 25752318.
  27. ↑ Engin B, Tufekci O, Yazici A, Ozdemir M (2009). “The effect of transcutaneous electrical nerve stimulation in the treatment of lichen simplex: a prospective study”. Clin Exp Dermatol. 34 (3): 324–8. doi:10.1111/j.1365-2230.2008.03086.x. PMIDΒ 19175614.

Editor-In-Chief:
C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karnik Raju Paila Bangaru, M.B.B.S.[2]

Looking for the patient version?

Back to the patient-friendly article